**Core Concept**
Gastroesophageal variceal hemorrhage is a life-threatening complication of liver cirrhosis, characterized by bleeding from enlarged veins in the esophagus or stomach. Management of variceal hemorrhage involves a combination of pharmacological and endoscopic interventions to control bleeding, prevent recurrence, and manage complications.

**Why the Correct Answer is Right**
The correct management of gastroesophageal variceal hemorrhage involves pharmacological interventions such as beta-blockers (e.g., propranolol) to reduce portal pressure, endoscopic variceal ligation (EVL) or sclerotherapy to obliterate the varices, and transjugular intrahepatic portosystemic shunt (TIPS) for refractory bleeding. The use of corticosteroids is not a standard treatment for gastroesophageal variceal hemorrhage.

**Why Each Wrong Option is Incorrect**
**Option A:** Beta-blockers are a standard treatment for gastroesophageal variceal hemorrhage, making this option incorrect.
**Option B:** Endoscopic variceal ligation (EVL) is a common treatment for gastroesophageal variceal hemorrhage, making this option incorrect.
**Option C:** Transjugular intrahepatic portosystemic shunt (TIPS) is a treatment option for refractory bleeding, making this option incorrect.

**Clinical Pearl / High-Yield Fact**
Corticosteroids are not a standard treatment for gastroesophageal variceal hemorrhage, and their use may even worsen liver function in patients with cirrhosis.

**Correct Answer:** D.